Bettenworth, Dominik <br/><br/>
Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance.  [electronic resource] 

 -  Molecular nutrition & food research  Jul 2014 
 - 1474-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1613-4133 
<br/><br/><label>Standard No.: </label>10.1002/mnfr.201300818  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Bacterial Agents--pharmacology<br/>CCAAT-Enhancer-Binding Proteins--genetics<br/>Citrobacter rodentium--drug effects<br/>Colitis--chemically induced<br/>Dextran Sulfate<br/>Disease Models, Animal<br/>Enterobacteriaceae Infections--drug therapy<br/>Feces--microbiology<br/>Female<br/>Gene Expression Regulation<br/>Humans<br/>Intestines--drug effects<br/>Leukocyte L1 Antigen Complex--blood<br/>Mice<br/>Mice, Inbred C57BL<br/>Microbial Viability--drug effects<br/>Neutrophils--drug effects<br/>Niacinamide--pharmacology